ALLIE ALFORD: Open Payments
NPI 1891206439 · MARIANNA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,968 in 100 payments from 13 companies in 2025. Trend: 2023 $1,121 · 2024 $1,173 · 2025 $1,968
Food & beverage: $1,781Education: $187
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 18 | $455 |
| Janssen Biotech, Inc. | 26 | $403 |
| Amgen Inc. | 13 | $284 |
| ABBVIE INC. | 14 | $245 |
| UCB, Inc. | 13 | $187 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| PFIZER INC. | 4 | $92 |
| GENZYME CORPORATION | 4 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: APLIGRAF, TREMFYA, OTEZLA, SKYRIZI, DUPIXENT, Bimzelx, CIBINQO, Sotyktu.
Industry payments across FL — which companies pay providers there.
